Moderna Inc at CECP Biopharma CEO Investor Forum (Virtual) Transcript
Thank you to CCP and the Forum for inviting me to be part of this discussion. I'm Andrew Edgecliffe-Johnson. I'm the U.S. Business Editor of the Financial Times. And I will not discuss which COVID vaccine I got, but I'm also at the FT, which is without fear or favor, so I'll try not to let it affect my questioning.
I will say though that I'm delighted to have this opportunity to introduce an executive who's had an outsized influence on the lives of many of us in recent months. Stephane Bancel is CEO of Moderna, and he's living proof that good things can come out of Davos because it was at the World Economic Forum early last year in January that he realized the world could be on the brink of its worse pandemic for 100 years.
He talked to my colleagues recently about sitting in Davos with 2 scientists sketching out disaster scenarios on napkins and the penny really dropping when he picked up his iPad and found out how many planes were flying in and out of Wuhan to cities in Asia, Europe and the U.S. But the fact that Moderna, a young company by biotech
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |